Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Pusch, T. Jentsch (2005)
Unique structure and function of chloride transporting CLC proteinsIEEE Transactions on NanoBioscience, 4
P. Fong (2004)
CLC‐K channels: if the drug fits, use itEMBO reports, 5
A. Kalgutkar, B. Crews, S. Rowlinson, Alan Marnett, K. Kozak, R. Remmel, L. Marnett (2000)
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.Proceedings of the National Academy of Sciences of the United States of America, 97 2
Alain Vandewalle, F. Cluzeaud, M. Bens, S. Kieferle, K. Steinmeyer, T. Jentsch (1997)
Localization and induction by dehydration of ClC-K chloride channels in the rat kidney.The American journal of physiology, 272 5 Pt 2
N. McCarty, Stefan McDonough, B. Cohen, John Riordan, Norman Davidson, Henry Lester (1993)
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoatesThe Journal of General Physiology, 102
H. Gögelein, D. Dahlem, H. Englert, H. Lang (1990)
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreasFEBS Letters, 268
M. Pusch, A. Liantonio, Lara Bertorello, A. Accardi, A. Luca, S. Pierno, V. Tortorella, D. Camerino (2000)
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.Molecular pharmacology, 58 3
R. Birkenhäger, E. Otto, M. Schürmann, M. Vollmer, Eva-Maria Ruf, Irina Maier-Lutz, Frank Beekmann, Andrea Fekete, H. Omran, D. Feldmann, D. Milford, N. Jeck, M. Konrad, D. Landau, N. Knoers, C. Antignac, R. Sudbrak, A. Kispert, F. Hildebrandt (2001)
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failureNature Genetics, 29
S. Kieferle, P. Fong, M. Bens, A. Vandewalle, T. Jentsch (1994)
Two highly homologous members of the ClC chloride channel family in both rat and human kidney.Proceedings of the National Academy of Sciences of the United States of America, 91 15
D. Simon, R. Bindra, T. Mansfield, C. Nelson-Williams, É. Mendonça, R. Stone, S. Schurman, A. Nayır, H. Alpay, A. Bakkaloğlu, J. Rodríguez-soriano, José Morales, S. Sanjad, C. Taylor, D. Pilz, A. Brem, H. Trachtman, W. Griswold, G. Richard, E. John, R. Lifton (1997)
Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type IIINature Genetics, 17
Zhiqiang Qu, H. Hartzell (2000)
Anion Permeation in Ca 2 Ϩ -activated Cl Ϫ Channels
Zhiqiang Qu, H. Hartzell (2000)
Anion Permeation in Ca2+-Activated Cl− ChannelsThe Journal of General Physiology, 116
Y. Matsumura, S. Uchida, Y. Kondo, H. Miyazaki, S. Ko, Atsushi Hayama, T. Morimoto, Wen Liu, M. Arisawa, S. Sasaki, F. Marumo (1999)
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channelNature Genetics, 21
Y. Lee, Q. Wang (1999)
Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.European journal of pharmacology, 378 3
S. Adachi, Shinichi UchidaS, H. Ito, Mimi Hata, M. Hiroe, F. Marumo, S. Sasaki (1994)
Two isoforms of a chloride channel predominantly expressed in thick ascending limb of Henle's loop and collecting ducts of rat kidney.The Journal of biological chemistry, 269 26
JR Vane, RM Botting (1998)
Mechanism of action of nonsteroidal anti-inflammatory drugsAm J Med, 104
Silke Brandt, T. Jentsch (1995)
ClC‐6 and ClC‐7 are two novel broadly expressed members of the CLC chloride channel familyFEBS Letters, 377
M. White, M. Aylwin (1990)
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.Molecular pharmacology, 37 5
A. Liantonio, A. Picollo, E. Babini, G. Carbonara, G. Fracchiolla, F. Loiodice, V. Tortorella, M. Pusch, D. Camerino (2006)
Activation and Inhibition of Kidney CLC-K Chloride Channels by FenamatesMolecular Pharmacology, 69
A. Livingston (2000)
Mechanism of action of nonsteroidal anti-inflammatory drugs.The Veterinary clinics of North America. Small animal practice, 30 4
A. Picollo, A. Liantonio, M. Didonna, L. Elia, D. Camerino, M. Pusch (2004)
Molecular determinants of differential pore blocking of kidney CLC‐K chloride channelsEMBO reports, 5
R. Estévez, T. Boettger, V. Stein, R. Birkenhäger, E. Otto, F. Hildebrandt, T. Jentsch (2001)
Barttin is a Cl- channel β-subunit crucial for renal Cl- reabsorption and inner ear K+ secretionNature, 414
S. Uchida, S. Sasaki (2005)
Function of chloride channels in the kidney.Annual review of physiology, 67
A. Liantonio, M. Pusch, A. Picollo, P. Guida, A. Luca, S. Pierno, G. Fracchiolla, F. Loiodice, P. Tortorella, D. Camerino (2004)
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers.Journal of the American Society of Nephrology : JASN, 15 1
CLC-K Cl- channels belong to the CLC protein family. In kidney and inner ear, they are involved in transepithelial salt transport. Mutations in ClC-Kb lead to Bartter’s syndrome, and mutations in the associated subunit barttin produce Bartter’s syndrome and deafness. We have previously found that 3-phenyl-CPP blocks hClC-Ka and rClC-K1 from the extracellular side in the pore entrance. Recently, we have shown that niflumic acid (NFA), a nonsteroidal anti-inflammatory fenamate, produces biphasic behavior on human CLC-K channels that suggests the presence of two functionally different binding sites: an activating site and a blocking site. Here, we investigate in more detail the interaction of NFA on CLC-K channels. Mutants that altered block by 3-phenyl-2-(p-chlorophenoxy)propionic acid (CPP) had no effect on NFA block, indicating that the inhibition binding site of NFA is different from that of 3-phenyl-CPP and flufenamic acid. Moreover, NFA does not compete with extracellular Cl- ions, suggesting that the binding sites of NFA are not located deep in the pore. Differently from ClC-Ka, on the rat homologue ClC-K1, NFA has only an inhibitory effect. We developed a quantitative model to describe the complex action of NFA on ClC-Ka. The model predicts that ClC-Ka possesses two NFA binding sites: when only one site is occupied, NFA increases ClC-Ka currents, whereas the occupation of both binding sites leads to channel block.
The Journal of Membrane Biology – Springer Journals
Published: Jul 21, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.